NCT06960772

Brief Summary

The aim of this study is to investigate the effects of flow ball phonation on the voice of professional voice users and elite vocal performers, both with and without functional voice disorders. Given the substantial vocal demands inherent to this population and their reliance on the voice for occupational purposes, this intervention may represent a valuable approach for the prevention and/or treatment voice disorders.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
144

participants targeted

Target at P75+ for not_applicable

Timeline
29mo left

Started May 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress29%
May 2025Sep 2028

First Submitted

Initial submission to the registry

April 28, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 7, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

May 8, 2025

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2028

Last Updated

May 7, 2025

Status Verified

April 1, 2025

Enrollment Period

2.6 years

First QC Date

April 28, 2025

Last Update Submit

April 28, 2025

Conditions

Keywords

Flow BallSOVTEprofessional voice usersStraw Phonation

Outcome Measures

Primary Outcomes (5)

  • Flexible Strobovideolaryngoscopy

    Laryngeal function determined with the Voice-Vibratory Assessment with Laryngeal Imaging (VALI) rating form (Poburka et al., 2017).

    baseline (before the intervention) and 3 weeks (immediately after the intervention)

  • Dysphonia Severity Index (DSI)

    DSI: A higher index indicates a better voice quality. The index ranges from -5 to +5 for severely dysphonic to normal voices. A more negative index indicates a worse voice quality. Values \> +5 are possible in subjects with excellent vocal capacities. A DSI = +1.6 is the threshold separating normophonic from dysphonic persons.

    baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

  • Acoustic Voice Quality Index (AVQI)

    A lower AVQI indicates a better voice quality. The index ranges from 0 to 10 for normal to severely dysphonic voices. An AVQI of 2.95 is the threshold separating normophonic from dysphonic persons.

    baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

  • Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V)

    The CAPE-V will be used to provide an auditory-perceptual evaluation of the voice quality. This visual analogue scale will examine the voice based on the parameters grade, roughness, breathiness, asthenia, strain, instability, pitch and loudness.

    baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

  • Voice Handicap Index

    VHI: A lower index indicates less impact of the voice impairment on the quality of life. The VHI ranges from 0 to 120.

    baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

Secondary Outcomes (10)

  • Maximum phonation time (MPT)

    baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

  • Fundamental frequency (fo)

    baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

  • Jitter

    baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

  • Shimmer

    baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

  • Noise to Harmonics Ratio (NHR)

    baseline (twice before the intervention), 3 weeks (immediately after the intervention), 3 weeks follow-up, 3 months follow-up

  • +5 more secondary outcomes

Study Arms (3)

Flow Ball

EXPERIMENTAL
Behavioral: Flow Ball Intervention

Straw Phonation

EXPERIMENTAL
Behavioral: Straw Phonation Intervention

Sham Intervention

SHAM COMPARATOR
Behavioral: Sham Intervention

Interventions

Participants receive an intensive intervention using the Flow Ball device over 3 weeks (a total of 5 hours), consisting of weekly: * 1 in-person guided session of 30 minutes * 2 guided online sessions of 15 minutes each (via teleconsult) * On the remaining 4 days of the week, participants perform independent training at home: 5 minutes, twice daily. This training is recorded using the app 'MyMedicoach'

Flow Ball

Participants receive an intensive intervention using a straw over 3 weeks (a total of 5 hours), consisting of weekly: * 1 in-person guided session of 30 minutes * 2 guided online sessions of 15 minutes each (via teleconsult) * On the remaining 4 days of the week, participants perform independent training at home: 5 minutes, twice daily. This training is recorded using the app 'MyMedicoach'

Straw Phonation

Participants receive an intensive intervention over 3 weeks (a total of 5 hours), consisting of weekly: * 1 in-person guided session of 30 minutes * 2 guided online sessions of 15 minutes each (via teleconsult) * On the remaining 4 days of the week, participants perform independent training at home: 5 minutes, twice daily. This training is recorded using the app 'MyMedicoach' The sham intervention uses breathing exercises through the Flow Ball, no phonation will be involved.

Sham Intervention

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • All genders
  • All ethnicities
  • years
  • Diagnosis of a functional voice disorder
  • Professional voice users

You may not qualify if:

  • Diagnosis of an organic voice disorder
  • Current participation in voice therapy
  • Previous phonosurgical interventions
  • Pregnancy
  • Smoking
  • Nasal or ear diseases
  • Neurological disorders
  • OBJECTIVE 2: PREVENTION
  • All genders
  • All ethnicities
  • years
  • Professional voice users
  • Current or previous diagnosis of a voice disorder
  • Current or previous participation in voice therapy
  • Previous phonosurgical interventions
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ghent University

Ghent, East-Flanders, 9000, Belgium

RECRUITING

Study Officials

  • Evelien D'haeseleer

    University Ghent

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 28, 2025

First Posted

May 7, 2025

Study Start

May 8, 2025

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

September 30, 2028

Last Updated

May 7, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations